Nerve-sparing, Robot-assisted Radical Prostatectomy Using a Personalized, 3D-printed Prostate Model for Selective Resection of Positive Surgical Margins
AURORA
1 other identifier
interventional
100
1 country
1
Brief Summary
To optimize precision for secondary resection (SR) in frozen section (FS) controlled nerve-sparing robot-assisted radical prostatectomy (NS-RARP) by using a personalized 3D-printed prostate model.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable prostate-cancer
Started Aug 2018
Typical duration for not_applicable prostate-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 26, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 26, 2022
CompletedFirst Submitted
Initial submission to the registry
July 17, 2023
CompletedFirst Posted
Study publicly available on registry
July 27, 2023
CompletedJuly 27, 2023
July 1, 2023
3.1 years
July 17, 2023
July 17, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
comparison of the primary surgical margin status in the FS with the tissue of the resulting SR and with the final surgical margin status
4 weeks
Secondary Outcomes (2)
Erectile function
1 year
Oncologic follow-up
1 year
Study Arms (1)
3D model guided SR
EXPERIMENTALA prostate model was 3D printed from preoperative pelvic MRI data and used during surgery to mark a positive surgical margin and guide secondary resection.
Interventions
A prostate model was 3D printed from preoperative pelvic MRI data and used during robot-assisted radical prostatectomy to mark a positive surgical margin and guide secondary resection.
Eligibility Criteria
You may qualify if:
- preoperatively planed and intraoperatively performed nerve-sparing approach (at least unilateral)
- suitable pelvic MRI for the creation of a personalized 3D prostate model,
- written patient consent
You may not qualify if:
- no nerve sparing performed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Basel, Switzerlandlead
- Intuitive Surgicalcollaborator
Study Sites (1)
Universitätsspital Basel Urologie
Basel, 4031, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christian CE Engesser, Dr.
University Hospital, Basel, Switzerland
- PRINCIPAL INVESTIGATOR
Jan JE Ebbing, PD Dr. med
University Hospital, Basel, Switzerland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 17, 2023
First Posted
July 27, 2023
Study Start
August 1, 2018
Primary Completion
August 26, 2021
Study Completion
August 26, 2022
Last Updated
July 27, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share